Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Dysphagia After Ischemic Stroke
NCT06335316Completed
- Sponsor
- Copka Sonpashan
- Start
- Jan 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine in dysphagia (2 arms), sponsored by Copka Sonpashan. Primary endpoint: Functional Oral Intake Scale at day 10. Started Jan 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT06335316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06335316.